rs1554888310
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_004329.3(BMPR1A):c.245G>T(p.Cys82Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C82Y) has been classified as Likely pathogenic.
Frequency
Consequence
NM_004329.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BMPR1A | NM_004329.3 | c.245G>T | p.Cys82Phe | missense_variant | 5/13 | ENST00000372037.8 | NP_004320.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMPR1A | ENST00000372037.8 | c.245G>T | p.Cys82Phe | missense_variant | 5/13 | 1 | NM_004329.3 | ENSP00000361107 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 19, 2016 | The p.C82F variant (also known as c.245G>T), located in coding exon 3 of the BMPR1A gene, results from a G to T substitution at nucleotide position 245. The cysteine at codon 82 is replaced by phenylalanine, an amino acid with highly dissimilar properties. An alteration, p.C82Y, in the same codon has been reported in a patient who met clinical criteria for juvenile polyposis syndrome and functional studies in a human kidney cell line demonstrated the variant protein had reduced bone morphogenetic protein signaling and deficient subcellular localization when compared to wild type (Howe JR et al. J. Surg. Res., 2013 Oct;184:739-45; Calva-Cerqueira D et al. Clin. Genet., 2009 Jan;75:79-85). Based on internal structural analysis, this alteration is predicted to be structurally destabilizing due to the loss of a cysteine-cysteine bridge (Keller S et al. Nat. Struct. Mol. Biol., 2004 May;11:481-8). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.001% (greater than 85000 alleles tested) in our clinical cohort. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at